Determinants of adherence to anti-hypertensive medications among adult hypertensive patients on follow-up in Hawassa Referral Hospital: A case-control study.
Adherence
Hawassa Referral Hospital
Morisky Medication Adherence scale
hypertension
Journal
JRSM cardiovascular disease
ISSN: 2048-0040
Titre abrégé: JRSM Cardiovasc Dis
Pays: England
ID NLM: 101598607
Informations de publication
Date de publication:
Historique:
received:
17
07
2019
revised:
27
10
2019
accepted:
13
11
2019
entrez:
4
2
2020
pubmed:
6
2
2020
medline:
6
2
2020
Statut:
epublish
Résumé
Hypertension is a global challenge which accounts for high morbidity and mortality rates in the world. The availability of effective anti-hypertensive medications does not result in a good outcome in controlling blood pressure which points towards poor adherence. Thus, this study was conducted to assess the determinants of adherence to anti-hypertensive medication among hypertensive patients on follow-up in Hawassa Referral Hospital. Institution-based case-control study was conducted on a sample of 289 clients from February to May 2018. Census was conducted on 1600 clients to select cases and controls. Then, systematic random sampling was used to select study subjects, and adherence was measured by Morisky medication adherence scale. The associations of variables were analyzed using bivariable followed by multivariable logistic regression analyses. The respondent's adherence to medication was found to be 67% as measured by Morisky medication adherence scale. The multivariate logistic regression analysis showed that medication adherence was found to be better in younger age (<45) (AOR = 3.8), clients living in urban areas (AOR = 6.84), those clients who had good knowledge (AOR = 3.13), those with no co-morbidities (AOR = 3.14) and patients who controlled their blood pressure (<140/90) (AOR = 2.35). The rate of medication adherence was found to be low, and hence educational interventions focusing on factors promoting adherence and patients' health support should be implemented.
Identifiants
pubmed: 32010442
doi: 10.1177/2048004019892758
pii: 10.1177_2048004019892758
pmc: PMC6967193
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2048004019892758Informations de copyright
© The Author(s) 2019.
Références
Patient Prefer Adherence. 2017 Mar 01;11:363-371
pubmed: 28280309
Drugs Context. 2019 Feb 04;8:212560
pubmed: 30774692
Int J Health Sci (Qassim). 2017 Sep-Oct;11(4):47-52
pubmed: 29085268
Ethiop J Health Sci. 2014 Jan;24(1):21-6
pubmed: 24591795
J Hum Hypertens. 2006 Apr;20(4):295-7
pubmed: 16424861
Lancet. 2009 Aug 15;374(9689):525-33
pubmed: 19683638
MMWR Morb Mortal Wkly Rep. 2011 Feb 4;60(4):103-8
pubmed: 21293325
Med Care. 2005 Jun;43(6):517-20
pubmed: 15908845
BMJ. 1990 Apr 14;300(6730):981-3
pubmed: 2344507
PLoS One. 2017 Jan 30;12(1):e0171255
pubmed: 28135324
Hypertension. 2019 May;73(5):e35-e66
pubmed: 30827125
PLoS One. 2007 Mar 14;2(3):e280
pubmed: 17356691
BMC Res Notes. 2016 Jan 02;9:3
pubmed: 26725042
J Epidemiol Glob Health. 2015 Jun;5(2):125-32
pubmed: 25922321
Lancet. 1997 Sep 13;350(9080):757-64
pubmed: 9297994
Heart. 2014 Jun;100(11):855-61
pubmed: 24694797
BMC Public Health. 2012 Apr 10;12:282
pubmed: 22490130
J Pharm Bioallied Sci. 2014 Apr;6(2):104-8
pubmed: 24741278
BMC Pharmacol Toxicol. 2017 Apr 5;18(1):27
pubmed: 28381241
PLoS One. 2013 Apr 25;8(4):e62775
pubmed: 23638143
JAMA. 1991 Jun 26;265(24):3255-64
pubmed: 2046107
East Mediterr Health J. 2002 Jul-Sep;8(4-5):579-92
pubmed: 15603041
J Hypertens. 2011 Jan;29(1):4-16
pubmed: 20881867
Integr Blood Press Control. 2017 Jun 16;10:1-7
pubmed: 28670137
J Clin Hypertens (Greenwich). 2008 May;10(5):348-54
pubmed: 18453793